SuperAccuracy Science & Technology Co., Ltd.
PrivateCompany Overview
SuperAccuracy Science & Technology Co., Ltd. is a medical technology company that develops innovative radiotherapy systems and precision oncology solutions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
radiotherapy systemmedical linear acceleratorcancer treatmenttreatment planning systemTPSradiation oncologymedical imagingprecision medicinedose reconstructionlinaconcology informaticsmedical deviceradiotherapy softwareOIMScancer tech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SuperAccuracy Science & Technology Co., Ltd. Comparables
Compare SuperAccuracy Science & Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zhongneng Medical Accelerator System (Guangdong) Co., Ltd. | 88% | |
| Doctor Technology | 84% | |
| Neusoft Medical Systems Co., Ltd. | 79% | |
SuperAccuracy Science & Technology Co., Ltd. Funding Rounds
Historical fundraising activity
SuperAccuracy Science & Technology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SuperAccuracy Science & Technology Co., Ltd.'s valuation, stock price, and market status.
See something wrong or outdated?